Cluster randomized controlled intervention trial on the effects of Cognitieve Adaptation Training (CAT) as a nursing intervention on the functioning of long-term hospitalized patients with severe mental illness.

Cluster randomized controlled intervention trial on the effects of Cognitieve Adaptation Training (CAT) as a nursing intervention on the functioning of long-term hospitalized patients with severe mental illness. - CAT

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON39931

Enrollment

100

Registered

2013-09-12

Start date

2013-09-20

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychiatric disorder severe mental illness

Interventions

CAT-interventions are based on two dimensions: (1) the patients* behavioral type (apathy vs. disinhibition vs. mixed), and 2) the patients* level of executive functioning, or the ability to plan and

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Living in residential psychiatric facility (department of long-term rehabilitation, Lentis Zuidlaren), willing to receive CAT on a weekly basis.

Exclusion criteria

Exclusion criteria: Indication by participant or clinician that the patient will not be able to participate in the study.

Design outcomes

Primary

Measure	Time frame
The study will include a baseline measurement (T0), assessments every three months during the first year (T3, T6, T9, T12), and an assessment at 1,5 and 2 years post baseline for the patients in the CAT-condition (T18 and T24). Primary outcome measures are the scores on the measurement for daily functioning and community participation. During all assessments, the primary instruments will be included, consisting of the Global Assessment of Functioning - Disability (GAF-D), and the Multnomah Community Ability Scale (MCAS), both instruments focusing on daily functioning. The GAF-D is a 100-point scale, assessing social and occupational functioning on a continuum ranging from 0 to 100. The MCAS is a semi-structured interview that is also being used during the CAT in the United States. The MCAS contains 17 items on domains focusing on interference with functioning, self efficacy, social competence, and behavioral problems. Assessment of the MCAS and GAF-D will take 45 minutes to complete.	—

Measure

Time frame

The study will include a baseline measurement (T0), assessments every three months during the first year (T3, T6, T9, T12), and an assessment at 1,5 and 2 years post baseline for the patients in the CAT-condition (T18 and T24). Primary outcome measures are the scores on the measurement for daily functioning and community participation. During all assessments, the primary instruments will be included, consisting of the Global Assessment of Functioning - Disability (GAF-D), and the Multnomah Community Ability Scale (MCAS), both instruments focusing on daily functioning. The GAF-D is a 100-point scale, assessing social and occupational functioning on a continuum ranging from 0 to 100. The MCAS is a semi-structured interview that is also being used during the CAT in the United States. The MCAS contains 17 items on domains focusing on interference with functioning, self efficacy, social competence, and behavioral problems. Assessment of the MCAS and GAF-D will take 45 minutes to complete.

—

Secondary

Measure	Time frame
Secondary outcome measures will be assessed at baseline (T0), after half a year (T6), after one year (T12), and for patients in the CAT-condititon after 1,5 and 2 years (T18 and T24). The measures will consist of empowerment (Nederlandse Empowerment Vragenlijst), quality of life (Short Form Health Survey - 12), clinical symptoms (Positive and Negative Syndrome Scale, Apathy Evaluation Scale, Negative Symptom Assessment), neuropsychological functioning (Letter Fluency, Modified Card Sorting Test, Digit Span forward and backward, Continuous Performance Task, and the verbal learning task immediate recall).	—

Measure

Time frame

Secondary outcome measures will be assessed at baseline (T0), after half a year (T6), after one year (T12), and for patients in the CAT-condititon after 1,5 and 2 years (T18 and T24). The measures will consist of empowerment (Nederlandse Empowerment Vragenlijst), quality of life (Short Form Health Survey - 12), clinical symptoms (Positive and Negative Syndrome Scale, Apathy Evaluation Scale, Negative Symptom Assessment), neuropsychological functioning (Letter Fluency, Modified Card Sorting Test, Digit Span forward and backward, Continuous Performance Task, and the verbal learning task immediate recall).

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)